- Home
- NATR vs KIO Comparison
NATR vs KIO Comparison
Compare NATR & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NATR | KIO |
|---|---|---|
| Founded | 1972 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.3M | 470.1M |
| IPO Year | 1995 | 2011 |
Fundamental Metrics
Financial Performance| Metric | NATR | KIO |
|---|---|---|
| Price | $25.28 | $11.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $21.33 | N/A |
| AVG Volume (30 Days) | 98.6K | ★ 297.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.83 | N/A |
| Revenue | ★ $454,364,000.00 | N/A |
| Revenue This Year | $7.30 | N/A |
| Revenue Next Year | $3.44 | N/A |
| P/E Ratio | $30.24 | ★ N/A |
| Revenue Growth | ★ 2.03 | N/A |
| 52 Week Low | $11.01 | $10.69 |
| 52 Week High | $28.14 | $12.83 |
Technical Indicators
Market Signals| Indicator | NATR | KIO |
|---|---|---|
| Relative Strength Index (RSI) | 43.07 | 19.49 |
| Support Level | $13.69 | N/A |
| Resistance Level | $26.96 | $12.15 |
| Average True Range (ATR) | 1.01 | 0.11 |
| MACD | -0.37 | -0.04 |
| Stochastic Oscillator | 37.64 | 25.32 |
Price Performance
Historical ComparisonAbout NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. The Fund's main objective is to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in a portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.